Mazdutide

Phase 2/3 Clinical Trials

peptideInjection

Dual GLP-1/glucagon receptor drug from Innovent Biologics. Strong weight loss and metabolic results. Already approved in China for obesity.

Key Facts

Classification
Peptide — Dual GLP-1/glucagon receptor drug with strong weight loss results.
Primary Benefits
Fat Loss (9/10) · Longevity (4/10) · Gut Health (4/10)
Administration
Injection
Typical Dose
Start at a lower escalation dose and increase to 4-6 mg per week. The GLORY-1 trial tested 4 mg and 6 mg maintenance doses. Meant for long-term use.
Evidence Strength
Emerging — 20 peer-reviewed studies referenced · Community sentiment 10/10
Stacks Well With
5-Amino-1MQ, MOTS-c, BPC-157
Legal Status
Phase 2/3 Clinical Trials · not prescribable in US · WADA prohibited

Start at a lower escalation dose and increase to 4-6 mg per week. The GLORY-1 trial tested 4 mg and 6 mg maintenance doses. Meant for long-term use.

🔥 Fat Loss

9/10

⏳ Longevity

4/10

🫃 Gut Health

4/10

🧊 Inflammation

3/10

Medical oversight requiredNot safe during pregnancy· 5 contraindications

Vendor	Variant	Price
Limitless Biotech	3mg	$104.99	Code: PSTACK10Buy
Skye Peptides	3mg	$94.99BEST	Buy